Ascentage Pharma (06855) receives subscription for a total of 38,600 shares by Yang Dajun, executive director and chairman of the board.

Zhito Finance APP News, Ascentage Pharma (06855) announced that the Company was informed by Dr. Yang Dajun, an executive director and chairman of the board of directors of the Company, that on September 23, 2026, September 24, 2026 and September 25, 2026, he acquired a total of 38,600 ordinary shares of the Company on-market, at a total consideration of approximately HK$1,157,100, at an average price of approximately HK$29.95 per share, representing approximately 0.01% of the total issued share capital of the Company as at the date of this announcement.